Comparison of the in vitro activity of echinocandins against Candida albicans , Candida dubliniensis , and Candida africana by time–kill curves

Data analysis 2

Fieke M. A. Wagemans, Mark J. Brandt, Marcel Zeelenberg · 2016 · 952 citations

Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals

Derek J. Sullivan, Ken Haynes, Désirée E. Bennett et al. · Microbiology · 1995 · 774 citations

Life Sciences, Microbiology, Molecular Biology +17

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Ana Espinel‐Ingroff, Maiken Cavling Arendrup, Michael A. Pfaller et al. · Antimicrobial Agents and Chemotherapy · 2013 · 208 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

Javier Pemán, Guillermo Quindós, Elena Eraso et al. · Journal of Antimicrobial Chemotherapy · 2012 · 159 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In Vitro Activity of Micafungin (FK-463) against <i>Candida</i> spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies

Erika J. Ernst, Ellen E. Roling, Chris Petzold et al. · Antimicrobial Agents and Chemotherapy · 2002 · 157 citations · Full text

Medicine, Microbiology, Pharmacology +17